40 results on '"Hüll, Michael"'
Search Results
2. Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments
3. [P4-139]: APPLICATION OF THE ‘A/T/N’ BIOMARKER CLASSIFICATION SYSTEM IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: CONVERSION RATES TO AD AND OTHER DEMENTIAS
4. [P3-164]: FUNCTIONAL CHARACTERIZATION OF A RARE GENETIC VARIANT IN PHOSPHOLIPASE Cγ2 WHICH IS ASSOCIATED WITH A BENEFICIAL EFFECT ON THE PROGRESSION OF ALZHEIMER's DISEASE
5. P1-426: The Effects of Structured Relearning Methods on Daily Living Task Performance of Persons with Dementia: Results from The Redali-Dem Trial
6. Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment
7. Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
8. P4‐273: Using neuropsychological criteria to distinguish between memory clinic patients with subjective cognitive decline and MCI
9. O2-02-04: The latent dementia phenotype δ is associated with the CSF Alzheimer's disease biomarker signature in subjects with mild cognitive impairment
10. O4-05-04: A four-center study on the effect of polygenic risk score on cerebrospinal fluid markers and memory decline in mild cognitive impairment patients
11. P1‐046: ROLE OF PLD3 RARE VARIANTS IN EUROPEAN SPORADIC ALZHEIMER'S DISEASE PATIENTS
12. P4-108: APPLYING AUTOMATED MR-BASED DIAGNOSING IN A MEMORY CLINIC: A PROSPECTIVE STUDY WITH MILD COGNITIVE IMPAIRMENT
13. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease
14. Syndrome-Specific Patterns of Regional Cerebral Glucose Metabolism in Posterior Cortical Atrophy in Comparison to Dementia with Lewy Bodies and Alzheimer's Disease-A [F-18]-Fdg Pet Study
15. P3-304: Longitudinal changes of MRI marker in Alzheimer's disease and frontotemporal dementia
16. O4-05-02: A phase II randomized, double-blind, parallel group, 26-week study of GSK-3 inhibitor tideglusib in Alzheimer's disease (ARGO trial)
17. P4-347: Which MCI subtypes convert to Alzheimer's disease in spite of negative CSF findings?
18. P4-084: Genome-wide association study using cerebrospinal fluid biomarkers beta-amyloid-42 and pTau181 in German samples of Alzheimer's disease
19. O3-13-03: ARGO trial
20. P2-013: CSF biomarkers and disease progression in an interrupted MCI trial
21. P4‐095: Diffusion and morphometric MRI correlates of language function decline: A longitudinal study in dementia
22. P4-055: Dual biomarker imaging with [11C]PIB and [18F]DG positron emission tomography in dementia
23. Quantifying change in individual subjects affected by frontotemporal lobar degeneration using automated longitudinal MRI volumetry
24. P1-096: Contralateral FMRI activation increase during confrontation naming in dementia patients with left temporal lobe atrophy
25. IC-P-062: Contralateral fMRI activation increases during confrontation naming in dementia patients with left temporal lobe atrophy
26. O1-04-08: Safety and efficacy of a galantamine/memantine combination in mild to moderate Alzheimer's disease - randomized controlled trial
27. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C
28. P2-357: Effects of resveratrol on microglial inflammatory and phagocytic activity
29. P2‐018: Deactivation of precuneus is reduced during naming in early dementia
30. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: Evidence for uncoupled regulation of mPGES‐1 and COX‐2
31. Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 load
32. Serotonin via 5‐HT 7 receptors activates p38 mitogen‐activated protein kinase and protein kinase C ɛ resulting in interleukin‐6 synthesis in human U373 MG astrocytoma cells
33. Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia
34. Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia
35. 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) Induces Apoptosis inHuman Neuroblastoma Cell Lines
36. Prostaglandin E2 Induces Interleukin-6 Synthesis in Human Astrocytoma Cells
37. Interleukin-1β Induces Cyclooxygenase-2 and Prostaglandin E2 Synthesis in Human Neuroblastoma Cells
38. Regulation of immediate-early gene expression in rat retinal ganglion cells after axotomy and during regeneration through a peripheral nerve graft
39. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
40. Quantifying change in individual subjects affected by frontotemporal lobar degeneration using automated longitudinal MRI volumetry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.